Computational Approach for Fast Screening of Small Molecular Candidates To Inhibit Crystallization in Amorphous Drugs
Authors:
- 27 August 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (10) , 2844-2855
Abstract
The applicability of the computational docking approach was investigated to create a novel method for quick additive screening to inhibit the crystallization taking place in amorphous drugs. Surface energy and attachment energy were utilized to recognize the morphologically most important crystal faces. The surfaces (100), (001), and (010) were identified as target faces, and the estimated free energies of binding of additives on these surfaces were computationally determined. The molecule of the crystallizing compound was included in the group of the modeled additives as the reference and for the validation of the approach. Additives having a lower estimated free energy of binding than the reference molecule itself were considered as potential crystallization inhibitors. Salicylamide, salicylic acid, and sulfanilamide with computationally prescreened additives were melt-quenched, and the nucleation and crystal growth rates were subsequently monitored by polarized light microscopy. As a result, computationally screened additives decelerated the nucleation and crystal growth rates of the studied drugs while the pure drugs crystallized too fast to be measured. The use of a computational approach enabled fast and cost-effective additive selection to retard nucleation and crystal growth, thus facilitating the production of amorphous binary small molecular compounds with stabilized disordered structures.Keywords
This publication has 31 references indexed in Scilit:
- Fast Surface Crystallization of Amorphous Griseofulvin Below T gPharmaceutical Research, 2010
- Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?Journal of Pharmaceutical Sciences, 2009
- Correlation Between Molecular Mobility and Crystal Growth of Amorphous Phenobarbital and Phenobarbital with Polyvinylpyrrolidone and L‐prolineJournal of Pharmaceutical Sciences, 2008
- Role of Thermodynamic, Molecular, and Kinetic Factors in Crystallization from the Amorphous StateJournal of Pharmaceutical Sciences, 2008
- A material science perspective of pharmaceutical solidsInternational Journal of Pharmaceutics, 2007
- Drug polymorphism and dosage form design: a practical perspectiveAdvanced Drug Delivery Reviews, 2004
- Physical Stability of Amorphous Pharmaceuticals: Importance of Configurational Thermodynamic Quantities and Molecular MobilityJournal of Pharmaceutical Sciences, 2002
- Amorphous pharmaceutical solids: preparation, characterization and stabilizationAdvanced Drug Delivery Reviews, 2001
- Evaluation of solubility parameter to predict apparent solubility of amorphous and crystalline cefditoren pivoxilPharmaceutica Acta Helvetiae, 1999
- Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systemsJournal of Pharmaceutical Sciences, 1999